AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 115 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,301,000 | +78.5% | 66,105 | +25.7% | 0.64% | +50.8% |
| Q3 2016 | $1,289,000 | -2.1% | 52,605 | -4.4% | 0.42% | -12.8% |
| Q2 2016 | $1,316,000 | -38.8% | 55,014 | -40.1% | 0.48% | -45.1% |
| Q1 2016 | $2,149,000 | -18.0% | 91,824 | +5.8% | 0.88% | -5.7% |
| Q4 2015 | $2,621,000 | +4.4% | 86,817 | +37.3% | 0.94% | -12.3% |
| Q3 2015 | $2,511,000 | -64.1% | 63,226 | -37.5% | 1.07% | -56.6% |
| Q2 2015 | $6,987,000 | +12.4% | 101,191 | -11.0% | 2.46% | +5.3% |
| Q1 2015 | $6,214,000 | -9.7% | 113,691 | -29.6% | 2.33% | -8.9% |
| Q4 2014 | $6,883,000 | -25.2% | 161,497 | -44.0% | 2.56% | -13.1% |
| Q3 2014 | $9,196,000 | +355.5% | 288,198 | +195.7% | 2.95% | +441.5% |
| Q2 2014 | $2,019,000 | – | 97,448 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |